Monthly Treatment vs Orals

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Monthly Treatment vs Orals

Postby RickB » Thu Apr 19, 2012 3:48 pm

I read that soon (1-2 years) a new long acting interferon beta will be on the market that will require only one monthly injection. The adverse events seem to be limited only to the days after the injection so one will be able to have the rest of the month without side effects. If it turns out to be true, would you switch to this new product? Thoughts on a monthly interferon vs the other oral or IV treatment options that all seem to have a less than stellar safety record?

Posts: 1
Joined: Thu Apr 19, 2012 3:45 pm


Re: Monthly Treatment vs Orals

Postby MarkLavelle » Thu Apr 19, 2012 8:14 pm

It all depends on how the safety/side effect data looks and whether I feel I've run out of more tested (and tolerable) options. I definitely wouldn't switch from Copaxone (every day, but absolute minimum side effects, for me) just to only have to shoot up once a month.

And in general, I'd hesitate to be in the first wave for any new (under 2 years) drug.

RRMS dx 3/3/11; Copaxone since 12/1/11
Family Elder
Posts: 178
Joined: Sat Dec 17, 2011 9:08 pm
Location: San Francisco Bay area

Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service